DAS Capital

DAS Capital

ABOUT US DAS Capital is a boutique investment advisory firm specializing in the life science sector with offices in Shanghai and Beijing, China. Unlike fully service investment banks, we primarily focus on three service lines Private Placement, M&A Strategy Development, and Mergers and Acquisitions Advisory. Since our inception in 2019, DAS Capital has advised clients on more than US$2 billion worth of deals for medical devices, biopharma, tools & diagnostics, and digital health & health tech companies. We have worked on a range from early-stage financing of start-ups up to mergers and acquisitions for public companies. However, most of our clients are in their growth and expansion stages. The team has extensive strategic consulting, investment, and industry experience. We position ourselves as the external “Strategic Business Development-SBD” team of growth-stage life science companies and leverage our expertise, industry insights, and network in the capital market and industry to support our clients’ growth. Our ECM team systematically covers over 4,000 local and overseas institutional investors, which include large Chinese conglomerates and industry heavyweights, public companies, financial institutions, government-backed funds, and family offices, as well as venture capital, private equity, mutual fund, and hedge fund players. Life Science Focus With a 100% Life Sciences focus and our dedication to solution orientation, we speak the same language as our clients and act not only as a service provider, we become a sparring partner. Strategic Consulting We support Life Sciences companies with strategic consulting and corporate finance advisory services, throughout their entire business cycle. All the way from start-up, via company growth to succession and exit. Dedicated Research One of our core capabilities is to deliver sector-specific, proprietary intelligence to our clients. We publish in-depth industry research reports for emerging fields of life science, most of which are the first comprehensive analyses in China. And those research reports have been featured in many of the nation’s top news outlets and major industry publications. Entrepreneurial Roots Like many of our clients, we started as a small bootstrapped venture with a few employees. We understand what it means to invest years into growing a private company, and we know what we do is mission-critical for the clients we serve. As business builders ourselves, we embrace this deeply personal role in their legacy, and we’re unyielding in our commitment to being our clients’ most trusted partner for independent, expert advice and unparalleled solutions to meet any challenge or need. OUR VISION AND MISSION Building China's leading boutique investment bank in the Life Science industry with "strategic thinking" value, offering transaction insight and value-added service to help entrepreneurs to achieve meaningful and lasting impact. OUR VALUE Service: We believe in the financial service industry, where excellent service is the key to success. Word of mouth remains the most powerful customer acquisition tool we have. Professionalism: We believe that out-professionalizing the competition is the only way to differentiate ourselves. Innovation: We believe the only sustainable competitive advantage comes from out-innovating the competition. Innovation is the key to catching new trends and delivering needed results. OUR BUSINESS Private Placement: We are created for start-ups and growth ventures, DAS as the right partner covering the specific areas tailored to each case for a successful journey. We make sure capital raising activities align with the company’s long-term strategy. We will build a custom team of capital-raising experts partnered with our industry specialists to leverage sector-specific insights that will help us to better position your company for maximum reception by investors. M&A Strategy Development: We help our corporate and private equity clients to form an M&A strategy, and assist them in how to create value from a business acquisition, combination or separation. And we help them to expand options of potential M&A, joint venture& alliance candidates and improve the odds of finding good opportunities that are off the radar of any other acquirer. Mergers and Acquisitions Advisory: No two deals are the same in the sell-side advisory field, which means we understand the uniqueness of your opportunity and goal. We start every relationship by listening and asking questions to better understand your transactional goals and then collaborating with you to create a customized plan to optimize your outcome. Our team will execute your transaction with the utmost skill, tenacity, and tact resulting in faster closing times, higher probability of close and market-leading multiples. For buy-side advisory, our industry-focused M&A advisors will combine deep sector expertise with superior transaction execution skills, and a vast network of strategic and financial relationships to help achieve your goals. Negotiating in the middle markets is not for the faint of heart. We manage a process that will help you identify, approach, and negotiate with potential middle-market targets that meet your criteria and achieve a successful outcome.

LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.